An IQVIA analysis looked at the 340B program’s growth under the Affordable Care Act.

ACA Played Key Role in 340B Growth, Drug Industry Consulting Firm Finds

September 12, 2024 Bella Czajkowski, National Correspondent 340B Report Views

The 340B program has outgrown patient demands and requires additional restrictions and oversight, according to a new report from a [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!